Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cellular and Molecular Medicine|August 7, 2009
Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and disseminationFrancisco Vega, Yogesh Davuluri, Jeong Hee Cho-Vega, et al.
American Journal of Cancer Research|November 16, 2022
Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphomaFang Yu, Hua He, Loretta J Nastoupil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Molecular Cancer Therapeutics|August 31, 2013
In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasomeLiang Zhang, Lan V Pham, Kate J Newberry, et al.
Blood|December 8, 2009
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathwayRosa Lapalombella, Leslie Andritsos, Qing Liu, et al.
The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.
The Journal of Clinical Investigation|September 28, 2018
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomasYuan Ren, Chengfeng Bi, Xiaohong Zhao, et al.
Science Translational Medicine|May 10, 2019
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphomaLiang Zhang, Yixin Yao, Shaojun Zhang, et al.
Molecular Cancer Research : MCR|November 6, 2020
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted AgentsManman Deng, Zijun Y Xu-Monette, Lan V Pham, et al.
Aging|December 13, 2016
RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphomaMingzhi Zhang, Zijun Y Xu-Monette, Ling Li, et al.
Pageof 5